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Although managed care seems to serve well the in-
terests of non-elderly enrollees and their payers, elderly
people face more risks. Chronic conditions, multiple prob-
lems, and more limited resources make them more vul-
nerable, whereas multiple payer sources make them more
complicated to cover. This synthesis of managed care de-
livered in Medicare and Medicaid demonstration projects
serving elderly beneficiaries shows that managed care
plans either select or attract enrollees who suffer fewer
frailties than those served in fee-for-service settings, ex-
hibit reluctance to enter rural markets, provide a broad
range of elderly-specific services, offer more compre-
hensive coverage and services, and result in greater per-
ceived access problems, particularly for vulnerable
subgroups. Plans operate more cheaply by using fewer
resources, even after adjusting for case mix differences.
Managed care enrollees tend to be more satisfied with
financial and coverage aspects, whereas fee-for-service
enrollees report higher satisfaction on other dimensions.
In acute care settings, process of care findings were
mixed, whereas clinical and self-reported outcome indi-
cators were no better and in some instances worse in
managed care. Long-term care enrollees, in the few stud-
ies reported, consistently faired worse in both the
processes and outcomes of care. These findings suggest
that further research on the effects of managed care in
its rapidly changing incarnations is needed, particularly
with respect to how to improve the quality of acute and
long-term care delivered to elderly people and the proper
role of government and other key actors in the health
care system.
Although elderly people report a high level of satis-
faction with their acute health care and Medicare cov-
erage (1), federal budget directors have called for major
reform of a cost trajectory deemed unsustainable (2).
Medicare is going broke; recent estimates indicate that
the hospital trust fund is due to run out of money in 5
years (3). Expenditures might be reduced if the s ° from
institutional to ambulatory settings now broadly under-
way throughout the health care system can be enhanced
and accelerated (4). Managed care promises such shifts,
as well as fewer procedures performed and reduced use
of expensive specialists.
Satisfaction with long-term care is much more prob-
lematic. Medicaid patients in particular suffer supply
shortages, discrimination, a limited range of service op-
tions, highly fragmented care, and uneven or poor qual-
ity care (5, 6). For many elderly people, Medicaid pays
all or part of their long-term care bill, provided they have
first spent most of their monthly income on health care
and related services. States lament that their spending
for long-term care is driving out all other priorities save
prisons (7). Efforts to shift the site of long-term care from
the heavily subsidized and expensive nursing home set-
ting to home- and community-based settings and to bet-
ter coordinate it through case managers have produced
all but unalloyed disappointments when tested in a fee-
for-service (FFS) environment. Costs have tended to rise,
not fall, whereas outcomes were but little bettered, typ-
ically for only small numbers of patients served, and usu-
ally for only the most fleeting periods (8, 9). Rationales
for shifting from a FFS to managed care delivery system
include improved service coordination, more precise tar-
geting, cost-savings, and better acute and long-term care
integration. If better managed, home care settings might
too prove cost-effective (9).
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PURPOSE AND CONTRIBUTION
What impact would a shift toward managed care have
on access, cost, and quality in the delivery of acute and
long-term care services to elderly people? Although an
important question given policyiiiakers’ increasing in-
terest in the managed care approach, a comprehensive
review that ties together the major research projects and
demonstrations in this area is lacking. This article in-
tends to fill this void by examining the American expe-
rience with managed care for elderly people in both the
acute and long-term care settings and to determine
whether or not the congeries of payment methods and
organizational forms grouped under the broad rubric
called managed care can indeed serve the interests of
both payers and patients in ways which represent an im-
provement over current FFS approaches.
Although Health Maintenance Organizations (HMO)
represent its most visible and well known configuration,
managed care includes a variety of financing and deliv-
ery forrns that fall along a continuum, ranging from FFS
with utilization management to the .s~~2e qua non of man-
aged care, the staff model HMO. In general, as organi-
zation and payment become increasingly intertwined
when moving from unmanaged FFS through managed
care’s alphabet soup, opportunities to monitor and con-
trol cost and quality typically increase (10). However,
the common link in all forms of managed care is altered
incentives for physicians and other providers, for en-
rollees, and for purchasers such as employers and gov-
ernment. Effects of these incentive changes are likely to
touch access and coverage, the organization and man-
agement of care, patterns of use and allocation of re-
sources, per capita and total spending, and a wide range
of patient outcomes. It is these effects in the context of
acute and long-term care for elderly people which are
synthesized in this article. The published research liter-
ature is reviewed to garner what evidence there is doc-
umenting differences between managed care and FFS in
terms of access, cost, and quality. The results indicate
that although managed care organizations tend to pro-
vide a broad range of age-appropriate services to elderly
enrollees, conserve resources, and operate at a lower
cost than FFS, they tend to shun chronically ill elderly
people or serve them poorly. Long-term care recipients
do worse, although the state saves money.
J P A ~ ~ &reg; DEMONSTRATIONS
Because managed care plans serve primarily non-
elderly people, most studies exploring the impact of man-
aged care on cost, quality, and access have focused on
the experiences of those aged 65 and under (see Miller
and Luft (11) for an overview). But elderly people have
special needs associated with chronic conditions that
require continuous rather than episodic care; many pre-
sent with deficiencies in multiple systems; many lack so-
cial resources; and a high percentage are high cost
patients. Not only is there a relative dearth of HMO ex-
perience in caring for elderly people, but the way in which
health care is financed is much more complicated than
financing for the under 65 population. For example, the
primary payer for acute care services (Medicare or pri-
vate insurance) depends on whether an individual con-
tinues to work or not. There may also be a secondary
payer, either a policy paid for by the individuals them-
selves (Medigap), retiree health benefits, or Medicaid.
Subacute services not covered by Medicare are either
paid for by acute care insurance benefits, out-of-pocket,
by Medicaid, or to a small but growing degree, by private
long-term care insurance. In the context of managed care
and elderly people, these disparate sources of financing
need to be taken into account. For these reasons, results
from studies musing non-elderly enrollees may not be trans-
ferable to those 65 and over. In response, a number of
Medicare and Medicaid programs and demonstrations
have been implemented by the federal and state gov-
ernments to test the usefulness of managed care in slow-
ing down expenditure increases in elderly populations.
Major evaluations include the Medicare At-Risk HMO
program and related demonstrations (12-14), the Social
Health Maintenance Organization study (S/HMO) (15),
the Arizona Health Care Cost Containment System
(AHCCCS) capitated acute care demonstration project
(16, 17), the Arizona Long-Term Care System evaluation
(ALTCS) demonstrations, and the Program of All-Inclusive
Care for the Elderly demonstrations (PACE) (18, 19). Much
of the research reported here is based upon these demon-
stration projects and programs. Table 1 highlights impor-
tant aspects of each.
EFFECTS OF MANAGED CARE
Theory suggests that managed care in the acute care
environment should reduce hospital use and costs, em-
phasize primary and preventive care, discourage inap-
propriate use of services, and substitute less expensive
care such as ambulatory, home health, and nursing home
care for more expensive delivery settings. In the long-
term care setting, it is expected to prevent hospitaliza-
tions and institutionalization of long-term care patients
1 Although both the acute and long-term care programs technically
fall under the same auspicies, the Arizona Health Care Cost Containment
System (AHCCCS), we refer to the long-term care program as the
ALTCS and the acute care program as the AHCCCS.
129
Table 1
Descriptions of Major Managed Care Programs and Demonstrations
a Number of enrollees at the time of the program’s major evaluation, the results of which are reported in this article.
bOpen (beneficiary choice among managed care plans, or managed care and FFS); mandatory (beneficiaries must enroll in managed care).
cursing facility certified; LTC, long-term care.
by supporting them in congregate living and home care
settings, improving coordination of care, and providing
patients with services uniquely required by a geriatric
population.
Table 2 highlights the acute and long-term care focus
of the studies reviewed, and briefly summarizes findings
explored more fully below in terms of access, resource
utilization and costs, and quality of care.
ACCESS
Managed Care Plans Enroll Healthier Individuals
Findings in the research literature show that plans ex-
perience favorable selection (see Hellinger (30) for a pre-
1988 review of the literature). Riley et al. (31) found that
the Medicare HMOs experienced mortality rates lower
than expected when compared to the number of deaths
in the local FFS sector. Lichtensten et al. (32) found no
adverse selection but evidence offavorable selection in
19 of 22 Medicare HMOs studied using functional health
status. Tax Equity and Fiscal Responsibility Act of 1982
(TEFRA) HMO evaluators Brown and Hill (28) reported
that enrollees tended to be younger, less likely to be nurs-
ing home users or Medicaid recipients, and less expen-
sive to care for than typical Medicare beneficiaries.
Similarly, Riley et al. (33), using data from the Medicare
Current Beneficiary Survey, found that, after controlling
for demographic characteristics and area of residence,
Medicare HMO enrollees were less likely to report suf-
fering from heart disease, functional limitations, and fair
or poor health. Moreover, average predicted costs using
measures of health status were much higher for FFS com-
pared to HMO beneficiaries.
In PACE demonstration sites, despite 136 cumulative
months of operation, only 888 clients were being served
by the end of 1992, a figure well below program expec-
tations, suggesting either niche marketing or skimming
to its evaluators (55), although the evaluators also list a
number of barriers to enrollment. According to program
staff, barriers include client resistance to PA,CE’s re-
quirement of 4 or 5 adult day health center visits per
week, client finances (e.g., unwillingness to pay copays,
apply for Medicaid, or divulge information on personal
finances), and loss of freedom of choice of providers.
Still, as of 1995, PACE enrollment had grown to 2,700 in-
dividuals with an average age of 80.0 years and an aver-
age number of medical conditions and Activity of Daily
Living dependencies of 7.8 and 2.7, respectively (19). This
indicates that despite any enrollment or selection prob-
lems it may be experiencing, the PACE program does
serve a rather old and impaired client population.
Wisner et al. (34) offer rare dissension in reference to
the Medicare HMO program, finding no evidence of fa-
vorable selection into HMOs in the Minneapolis market.
To the extent that favorable selection exists, it might be
due to the problem that sicker individuals are reluctant





a+=better than FFS or positive result; -= worse than FFS or negative result, nd = no different from FFS or neutral result.
tionship which is often required when enrolling in a closed
panel HMO. Only healthier seniors may be willing to make
such a switch. Alternatively, it might be due to efforts by
managed care organizations to discourage sicker indi-
viduals from enrolling. Most studies do not attempt to elu-
cidate the causal factors behind favorable selection. In
either case, favorable selection raises questions about
managed care’s viability for serving a frail and chronically
ill elderly population, particularly those in need of long-
term care. One response developed very recently by state
Medicaid programs for their nonaged populations may
also work for aged people, however, although it has not
yet been applied to aged populations. A single contractor
is hired as a broker, charged with recruitment, patient
counseling about options, and assignment of the patient
to a managed care plan which is required to accept all
Medicaid patients assigned by the broker.
Despite evidence of favorable selection, a survey of
managed care plans (35) found a high level of reluctance
among managed care plans to assume the risk of caring
for senior citizens. Plans feared unlimited liability for
care, weak demand, and adverse selection. In deference
to trepidations such as these, S/f1M&reg; sites were allowed
to limit the number of individuals with one or more ac-
tivities of daily living impairments to 5% of enrollment.
Nevertheless, recent evidence from the Medicare risk
program indicates that such attitudes may be changing;
the number of plans entering into such contracts in-
creased from a low of 93 in 1991 to 271 in 1996 (12). The
ALTCS, a Medicaid program capitated for the state’s poor
population, had 20,361 enrollees as of July l, 1995, and
served a significantly impaired population; 72% of home-
and community-based enrollees and 96.7% of 1990-1991
skilled nursing facility clients were dependent in toilet-
ing or eating, the highest level of dependency (56). This
compares to 65.4% of 1985 National Nursing Home Survey
residents who were similarly disabled (57).
Managed Care N Not Work in Rural Areas
Despite managed care’s potential, it may not work in
sparsely populated areas. Ricketts et al. (36) make the
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point that &dquo;Some types of plans require a threshold num-
ber of subscribers to support capital needs or provide
some actuarial basis for distributing risks.&dquo; They note that
higher county population density is strongly associated
with better access to HMO services, with adjacency to a
metropolitan county strongly predicting whether or not a
rural county is included in the service area of an HMO.
This is a critical point, they report, because during the last
U.S. Census, more than a quarter of elderly Americans
were found in rural areas, and they tended to be sicker
and more impaired than urban dwellers.
Two of four HMOs in the Twin Cities area dropped
their rural counties and enrollees in 1988 after finding
that covering them was no longer profitable. Claims vary
as to why. Either (the plans’ view) Health Care Financing
Administration (HCFA) paid too little for rural enrollees
(it paid less than for urban enrollees), or (a cynical view)
enrollees began to use services for the first time (34).
Benefits Be Age-Appropriate and More
Comprehensive
A recent survey of HMOs (37) showed arrangements
had been made for the following elderly-relevant ser-
vices : home health (91%), pharmacies (81%), nursing
home (75%), hospices (30%), rehabilitation centers (26%),
and subacute care facilities (12%). Other studies have
shown a willingness to affiliate with nursing homes and
other aging network providers (38), to hire geriatricians
and geriatric nurse practitioners (39), and to develop
long-term care and other aging-relevant services (40).
On the acute-care side, Medicare HMOs provide more
extensive coverage than Medicare’s traditional FFS pack-
age. In fact, most offer supplemental benefits in the way
of additional services or coverage for Medicare cost-
sharing, and although they could charge a premium for
these add-ons, only one-third do (12). Take prescription
drugs, for example. The Medicare Current Beneficiary
Survey shows that although prescription drug use rates
are similar for Medicare FFS and HMO beneficiaries, out-
of-pocket prescription drug expenditures for HMO en-
rollees are half that of FFS enrollees (41). Similarly, a
1996 Physician Payment Review Commission (PPRC)
sponsored survey by Mathematica Policy Research of
beneficiaries enrolled in Medicare risk plans found that
more than three-quarters paid no premium and that 83%
received coverage for outpatient prescription drugs, a
benefit not covered by Medicare’s traditional package of
benefits (42).
Indeed, many elderly beneficiaries enroll in managed
care to obtain coverage for a broader range of services.
The Medicare Capitation Demonstration found that in-
dividuals with a Medigap policy were less likely to make
the switch to managed care from FFS (20). More re-
cently, 1993 data from the Medicare Current Beneficiary
Survey indicate that those with incomes below $10,000
per year are less likely to be enrolled in HMOs, most
likely due to their status as Medicare-Medicaid dually
eligibles, whereas wealthy enrollees are also less likely
to be so enrolled, possibly reflecting the limited attrac-
tiveness of supplemental HMO benefits (43). Approx-
imately 50% of at-risk beneficiaries surveyed in the 1996
PPRC-sponsored study by Mathematica indicated that
costs or benefits represented their primary motivations
for joining (42).
Some Enrollees Perceive Restricted Access to
Services
The 1996 PPRC-sponsored study found that the vast
majority of Medicare risk plan enrollees saw a physician
during the previous year, rated continuity of care highly,
believed plans provided enough information upon initial
enrollment, and perceived no barriers to access such as
care delays, language problems, or lost or misplaced
medical records. Few reported problems obtaining ac-
cess to hospital care, specialty care, or home health care.
On the other hand, many beneficiaries reported that they
had problems getting questions answered, were unaware
of their rights to appeal plan decisions, and were not en-
couraged to have a physical examination or health as-
sessment after joining. The researchers also found that
vulnerable populations such as those over the age of 85,
non-elderly disabled people, functionally impaired peo-
ple, those in fair or poor health, and those in worsening
health, experienced more access problems than their
less vulnerable counterparts. (42).
Using the Medicare Current Beneficiary file as a com-,
parison group, the researchers found that risk plan en-
rollees experienced more access problems than their
counterparts in FFS. Although 13.3% of managed care
enrollees reported at least 1 of 6 access problems sur-
veyed, just 4% of FFS beneficiaries answered affirma-
tively when asked if they had trouble obtaining health
care when they wanted or needed it (42). The gap in per-
ceived barriers to access between HMO and FFS en-
rollees widens for certain groups such as the non-elderly
disabled (24.9% versus 14.1%), those over the age of 85
(10.1% versus 3.1%), and those in fair or poor health (23.6%
versus 9.3%). In short, problems getting wanted services
are likely to be experienced by a substantial percentage
of chronically ill people if they enroll in managed care.
Of course this assumes that FFS represents the gold
standard, which is not necessarily the case. Indeed, in-
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terest in managed care has been driven primarily by its
purported ability to hold down potentially avoidable re-
source use and costs. For policymakers, the challenge
is to maintain an acceptable level of access and quality
while tapping managed care’s potential to achieve their
budgetary objectives.
Evaluators of the acute care portion of the AHCCCS
program found a nonstatistically significant difference
in the access of Social Security Income (SSI) recipients
to emergency care in the Arizona (prepaid) and New
Mexico (FFS) Medicaid programs in 1985. Of those who
&dquo;reported that they needed emergency care&dquo; in Arizona,
19.9% reported that they had &dquo;any difficulty&dquo; in getting
it, compared to 13.3% in New Mexico (50). There was no
statistically significant difference in access to urgent care
or routine care, however, or in the method or amount of
time it took to get to the usual place where care is re-
ceived. However, SSI recipients in the AHCCCS program
were more likely to report that the place where they usu-
ally receive medical care had at least one care location
open in the evenings or weekends. The evaluators note
that this difference may be just the kind of appropriate
shift of resources most desired from managed care.
RESOURCE UKE COSTS
Utilization an Costs re Reduced or Shifted
In the Medicare Competition Demonstration, hospi-
tal inpatient use was lower for managed care enrollees
compared to FFS enrollees in both discharges and days
per 1,000 enrollees (22). Others (21) found total charges
per month in an old group-HMO participating in the
Medicare Capitation Demonstration program to be nearly
40% lower than FFS, whereas costs incurred by patients
who died were 27% below that of their FFS counterparts.
Mathematica and Virginia Commonwealth University
researchers (14) found that TEFRA HMO enrollees had
the same number of hospital admissions, but a lower av-
erage length of hospital stay than did FFS clients. HMOs
were more likely to be discharged to lower cost settings.
For example, HMO stroke patients were more likely to
go to nursing homes and less likely to go to more ex-
pensive rehabilitation hospitals, whereas HMO colon
cancer patients were more likely to be discharged to
their own homes than to nursing homes or rehabilita-
tion hospitals (14). Moreover, HMO enrollees, discharged
more often to these alternative settings, experienced
shorter skilled nursing facility visits. The authors also
found a 50% reduction in home health visits but no dif-
ference in the number of clients receiving such care. The
greatest HMO versus FFS decrease in hospital days and
home health visits was for enrollees with poor health,
dependent in activities of daily living (personal care) or
instrumental activities of daily living (grooming, cook-
ing, and so forth), or who died within 9 months of the
interview (14).
In some cases, these researchers found that HMO en-
rollees were more likely to consume certain services.
For example they were more likely to visit a physician
once a year and have a physical examination. However,
fewer HMO enrollees visited a physician once a month
or more. To a small degree, HMO enrollees were more
likely to have a skilled nursing facility stay (28). The prob-
ability of admission for enrollees in poor health or with
functional impairments increased for HMO enrollees
compared to FFS clients.
Despite the variation in findings across different ser-
vices, the team’s overall conclusion was that, after ad-
justing for favorable selection and insensitive capitation
payments, HMOs in the study spent about 10.5% less for
hospital, physician, home health, and skilled nursing care
than would have been spent for the same enrollees in a
FFS payment system (14). Critics have noted that results
were based on only first year enrollees. Results might
differ over a longer period of observation.
Evaluators estimated that between 1983 and 1993 the
acute care side of the AHCCCS saved $196,741 million
compared to what would have been spent if a traditional
Medicaid program had been operating in the state (16).
However, only a little more than $7,022 million in these
savings were generated by aged SSI recipients (most
came from Aid to Families with Dependent Children el-
igibles and the SSI disabled). Still, the average annual
per capita growth for aged SSI recipients over the 11 1
years studied was less for the AHCCCS (13.7%) than if a
traditional Medicaid program had been in place (15.3%).
A comparison of SSI/Medicare recipients in the AHCCCS
from October 1987 to March 1989 to Medicare enrollees
in HMOs surveyed by the Group Health Association of
America in 1987 found that the former had one more
physician encounter per member per year but 26% fewer
hospital days, 11% fewer admissions, and a 14% shorter
average length of stay (51).
In the ALTCS, McCall et al. (17) found a roughly 16%
average annual reduction in what Arizona spent per capita
for elderly and physically disabled long-term care
Medicaid patients from what would have been spent in
a typical Medicaid program. Most of the savings came
from reduced hospital and nursing home use, which was
less than offset by higher ambulatory care and adminis-
trative expenses. In that same evaluation of the ALTCS,
Weissert et al. (56) concluded that nursing home costs
were probably 40% lower than they would have been with-
out several important plan features including capitation,
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stringent eligibility screening, an extensive array of home-
and community-based services, strong financial incentives
to make placements in home and community care rather
than nursing homes, and very low payments for home care
services. lVIcCal1 et al. (17) found no difference in the over-
all level of services consunied, but a substantial realloca-
tion from inpatient to outpatient. (But quality problems
resulted, see below and Table 2.)
An exception to the usual pattern of lower inpatient
use was reported by Wan (49) who found that dually el-
igible Medicaid managed care demonstration clients had
longer hospital stays for medical procedures than did
FFS comparison group members. Similarly, results var-
ied across S/HMO sites depending on enrollee disability,
market competition, premium rates, and level of ex-
panded benefits, but in general did not show a pattern
of consistent savings or a consistent ability to hold down
inpatient and institutional use (52).
Despite exceptions, the general pattern of findings
suggests cost savings in acute care settings associated
with managed care. Care seems to be rationed in situ-
ations in which it can be rationed, and provided more
generously when it may prove efficacious. As noted
above, however, enrollees may not always agree with
rationing decisions.
OAF CARE
Researchers have focused on various criteria for mea-
suring quality, such as enrollee satisfaction, the processes
of care (preventive care use, emergency care use, early
detection and diagnosis, screening, care management,
continuity, appropriateness, post-discharge planning),
and the outcomes of care (pain and suffering, post ad-
mission complications, functional status decline or re-
covery, and mortality). Although the results of these
studies are mixed, they can be summarized as showing
managed care enrollees less satisfied on most dimen-
sions but financing and coverage, no clear systematic
difference between the managed care and FFS perfor-
mance on acute care processes, worse clinical and self-
reported outcomes in acute managed care, and a
consistent inferiority in tenns of both the processes and
clinical outcomes of long-term care in the few studies
based in such settings.
Enrollee ~~’~~~~~~~6&reg;~
Enrollees Satisfied with Care. although
researchers have generally found that elderly people rate
their overall satisfaction with both HMO and FFS deliv-
ery highly, HMO enrollees typically report being more
satisfied than FFS beneficiaries with the financial and
coverage aspects of their plans and less satisfied with
most other dimensions. Thus, a comparison of Medicare
HMO and FFS beneficiaries found the former to be less
satisfied with the care process, plan access, provider
choice, and perceived quality and outcomes, but signif-
icantly more satisfied with costs while being less likely
to report lacking coverage for needed services (14).
Results from the S/I~1VI&reg; study showed similar results
but for impaired enrollees only. Although unimpaired
members reported higher satisfaction than FFS benefi-
ciaries in all areas except interpersonal relations (where
there was no difference), impaired enrollees reported
lower satisfaction in all areas but finance and benefits
(where they were more satisfied) (53). In 1985, evalua-
tors of the acute care side of the AHCCCS found that SSI
recipients in the Arizona Medicaid program were less
likely to report being very satisfied with their overall
medical care compared to their counterparts in New
Mexico (56.1% versus 73%) (50). In particular, Arizona
respondents reported being slightly less satisfied, on av-
erage, with waiting time, evening and weekend avail-
ability, information giving, and courtesy and
consideration. Alternatively, Arizona respondents re-
ported being slightly more satisfied, on average, with
ease and convenience and costs paid out of pocket for
medical care received.
Both the TEFRA and AMMO evaluators concluded
that lower costs and more comprehensive benefits
tended to offset lower satisfaction with other attrib-
utes. Thus, approximately 93% of respondents in the
TEFRA evaluation said that they would recommend an
HMO to a friend or relative, whereas impaired elderly
people were less likely to disenroll than their unim-
paired counterparts (14, 53). Although the 1996 PPRC
study similarly found that 91% of Medicare HMO bene-
ficiaries would recommend their plan to a friend or rel-
ative, close to one-quarter indicated that they would
not do so for someone who was seriously ill or suffered
from a chronic condition (42). Nevertheless, more than
90% ranked their plans as excellent or very good/good
on dimensions such as coverage, waiting time, choice
of specialists, value for money, and ease seeing a pri-
mary care physician of choice.
Process of Care
Process of Care Findings Are Mixed. Many studies
employed process of care and resource use indicators
as quality measures. The connection between resource
use and quality depends crucially on the perceived ap-
propriateness of the service in question. On the one hand,
reduced utilization might represent improved quality due
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to decreased use of inappropriate services. On the other,
it may mean a reduction in necessary services.
Some Acute Managed Care Processes of Care
Were Better: (a) A study of the eight Medicare Competi-
tion Demonstrations showed that they were more likely
to provide elements of routine and preventive care and
examine occult blood and endoscopy or barium enemas
among colorectal cancer patients (23, 24). (b) Riley et
al. (44) found earlier stages of diagnosis in Medicare
HMO enrollees compared to FFS clients for breast can-
cer, cervix, colon, and melanomas. No differences were
found for prostate, rectum, buccal cavity and pharynx,
bladder, uterus, kidney, and ovary cancers. The authors
concluded that &dquo;HMO enrollees were diagnosed at ear-
lier stages for cancer sites for which effective screen-
ing services are available&dquo; (44). The strongest HMO-FFS
differences were found in those geographic areas with
the largest and most mature ~I~~s. (c) Compliance with
process of care criteria for Medicare beneficiaries with
acute myocardial infarction was found to be greater
among Medicare HMO than FFS providers (45). (d)
Clement et al. (46) found that, among individuals with
joint pain, physician visits and medication were more
likely to be prescribed in the Medicare HMOs. (e)
Congestive heart failure patients were more likely to re-
ceive advice on salt intake and have a 1 week follow-up
after discharge in eight Medicare Competition
Demonstration HMOs (25). Similarly, HMO enrollees
with diabetes were more likely to receive aspects of eye
care and urinalyses (26). (f) The TEFRA HMO evalua-
tion showed that stroke patients were more likely to
have post discharge speech and physical therapy planned
(14). (g) The 1996 PPRC sponsored survey by
Mathematica found that many beneficiaries were en-
couraged to obtain preventive care; 22% reported re-
ceiving a hearing test and 71% a cholesterol test, with
glaucoma tests, flu shots, mammograms, and colorec-
tal cancer screening falling somewhere in between. Using
the Medicare Current Beneficiary Survey for compari-
son, the researchers found that HMO enrollees were
more likely to obtain a mammogram and flu shot than
their FFS counterparts (42).
Other Acute Managed Care Pr-ocesses of Care Were
Worse. (a) Evaluation of eight Medicare Competition
Demonstrations showed longer delays between pre-
senting symptoms of gastrointestinal bleeding and di-
agnosis as well as greater preoperative imaging for
colorectal cancer patients (24). (b) A comprehensive
evaluation of the TEFRA program found a shorter dis-
tance between tumor and the margin of resection in
colon cancer patients (14). (c) A Medicare risk program
study showed that specialist referrals, follow-up rec-
ommendations, and progress monitoring were more
likely among FFS beneficiaries with joint and chest pain
(46). Those with chest pain in a FFS setting were also
more likely to receive physician visits. (d) A study of
eight Medicare Competition HMOs showed less frequent
changes in medication for congestive heart failure pa-
tients with uncontrolled hypertension in the HMO com-
pared to FFS setting (25), whereas FFS clients with
diabetes were much more likely to receive flu shots (26).
(e) The TEFRA evaluation showed that HMO clients
with stroke and colon cancer had fewer tests, proce-
dures, and services, and a shorter average length of stay,
and less time in intensive care units. For example, stroke
patients in the HMO setting received less physical ther-
apy in the hospital (14).
Still Other ~le~cte Managed Care Processes of Care
Were No Different. (a) The TEFRA evaluation found sim-
ilar signs of stroke upon admission to indicate no delay
in urgent hospitalization in the HMO relative to the FFS
setting (29). (b) Clement et al. (46) found no difference
in physical therapy prescription and roentgenograms
performed among Medicare HMO and FFS beneficiaries
with joint pain, and no difference in electrocardiograms
performed, and medication and treatment prescribed
among those with chest pain. (c) Retchin et al. (25, 26)
found little difference in the initial evaluation of con-
gestive heart failure patients, whereas among elderly
people with diabetes, similar management and compli-
cation detection strategies characterized the eight
Medicare Competition Demonstrations sites and their FFS
counterparts (25, 26). (d) Retchin et al. (29) reported that
significant differences did not exist in the medications
prescribed to stroke patients in TEFRA HMOs compared
to FFS. (e) TEFRA evaluators noted that most indicators
of quality for colon cancer showed no difference (amount
of colon removed, blood lost, number of lymph nodes re-
moved) (14). (f) Evaluators of the acute care portion of
the AHCCCS found no difference in the receipt of pre-
ventive care (physician, eye and dental examinations,
blood pressure check, pap smear, and breast examina-
tion) between Arizona and New Mexico SSI recipients in
their respective Medicaid programs in 1985 (50).
Some Long- Term 1Vlanaged Care Processes of Care
Were Worse. An evaluation of the ALTCS found that nurs-
ing home residents in Arizona (all of whom were enrolled
in managed care) were less likely to be offered influenza
vaccine than were Medicaid nursing home residents in
New Mexico (17). (Evaluators warned that although the
overall results of this study seem to indicate that the qual-
ity of care in the capitated system was lower, the find-
ings could have been influenced by sample selection,
data collection methods, less than perfect quantifica-
tion of independent variables, and by the choice of qual-
ity indicators.)
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Other Lo~g-Term Managed Care Processes of Care
Were No Different. No significant differences existed be-
tween ALTCS nursing home residents and the New Mexico
control group with respect to the incidence of patient falls
or fractures in the use of psychotropic drugs (17).
Clinical and Self-Reported Outcomes of Care
Most Acute Managed Care Outcomes Were No
Better than FFS, ere Some Long- Term Managed
Care Outcomes Were Worse. Most evaluations did not
find major differences in the acute care quality between
HMO outcomes and those observed in the Medicare, FFS
system. However, in some cases, subsets of these findings
suggest that acute care quality in HMOs, as measured by
outcomes, might be below that received by FFS benefi-
ciaries. Moreover, the few studies examining long-term
care outcomes provide evidence for the assertion that FFS
providers performed better than their HMO counterparts. .
Some Acute Managed Care Outcomes Were No
Different. (~.) Ware et al. (47) compared the 4-year change
in summary mental health scores from the Medical
Outcomes Study 36-Item Short-Form Health Survey
among Medicare beneficiaries served in an HMO or FFS
setting in three study sites (Boston, Chicago, and Los
Angeles). After controlling for demographic, chronic dis-
ease, and study design factors, the authors found that
the 346 elderly HMO patients included in the study were
more likely than the 476 FFS patients to report better
mental health outcomes after 4 years (26% and 13%, re-
spectively, P < 0.03). The authors point out, however,
that this result was &dquo;due entirely to the better perfor-
mance of HMOs in one study site.&dquo; In the other two sites,
no differences were found between Medicare beneficia-
ries in HMOs and FFS. (b) Based on their overall obser-
vations from the TEFRA study on stroke care, these
evaluators concluded that quality is equal in HMOs and
FFS. Moreover, they stress that HMOs seem to econo-
mize on inpatient care without affecting outcomes (29).
(c) Manton et al. (54) determined that S/HMOs performs
adequately with respect to the healthy and acutely ill in
view of various health outcomes, (d) Carlisle et al. (45)
found no difference in mortality rates due to acute my-
ocardial infarction in Medicare HMOs and FFS. (e)
Clement et al. (46) found no difference between Medicare
HMO and FFS enrollees in the likelihood of symptom
improvement among those with chest pain as well as no
difference in the complete elimination of joint and chest
pain. (f) Retchin et al. (27) found no difference in func-
tional status decline between HMO and FFS enrollees in
the Medicare Competition Demonstrations, (g) An eval-
uation of the TEFRA program found similar death, hos-
pital readmission, and post-admission complication rates
among colon cancer and stroke patients within the HMO
and FFS settings (14).
Some Acute Managed Care Outcomes Were Worse. (a)
Ware et al. (47) found that the 346 elderly HMO patients in-
cluded in the study were more likely than the 476 FFS pa-
tients to report a decline in physical health outcomes after
4 years (54% and 28%, respectively, P < 0.001). Moreover,
such decline existed in all three study sites ex ed. (b)
Shaughnessy et al. (48) compared the outcomes of patients
served by nine Medicare risk HMO-owned home health care
agencies, 15 pure FFS agencies, and 14 ~edlc&reg;ntractual
agencies (i.e., those that serve a significant number of both
HMO and FFS beneficiaries) located in 18 states. The au-
thors compared HMO and FFS patients across a variety of
outcomes, including status improvement and stabilization
(using such indicators as activities of daily living and in-
strumental activities of daily living), mortality, discharge to
independent living, hospitalization, and discharge to hos-
pital for emergent or urgent care. The author’s conclude
that case-mix-adjusted outcomes of home health care are
better for FFS than HMO patients. They found that: &dquo;... an
overall trend of superior case-~-adjusted outcomes for
FFS patients was apparent in terms of the relative unifor-
mity of higher values for most outcome measures and...
they nearly always indicated superior outcomes for FFS
patients.&dquo; Favorable outcomes for FFS were found for a
wide variety of outcomes including activities of daily living
such as eating, toileting and transferring, instrumental ac-
tivities of daily living such as grooming and shopping, and
medications management. (c) Clement et al. (46) found that
symptom improvement was more likely to occur among
Medicare FFS than HMO beneficiaries with joint pain. (d)
The TEFRA evaluation revealed that stroke victims had
greater motor and speech defects at discharge in HMOs (al-
though no difference in sensory deficits) (14).
Some Long- Term Managed Care Outcomes Were Worse.
(a) Nursing home residents in the ALTCS program were
more likely to experience a decubitus ulcer, fever, and
catheter insertion than nursing home residents served by
the New Mexico Medicaid program (17). (b) Manton et al.
(54) concluded that S/I4P/I&reg;s do not perform well for im-
paired or acutely ill individuals with chronic impairments.
Moreover, they assert &dquo;that LTC services provided in
S/HMOs were not effective in improving... functional sta-
tus--especially among elderly females who have the great-
est LTC needs&dquo; (54). Overall, FFS female patients had a
significant advantage in life expectancy; likewise, FFS male
patients also experienced outcome advantages (54).
SUMMARY OF EFFECTS
Although some studies divert from a common theme,
most point to a similar set of conclusions: (a) managed
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care provides more comprehensive coverage and ser-
vices to healthy patients and provides a broad range of
age-appropriate services to elderly enrollees; (b) man-
aged care restricts access, particularly for chronically ill
elderly people and those in rural areas, and experiences
favorable selection and attrition so that its case mix is
less debilitated than the average population (although
there are important exceptions and a growing willing-
ness to enroll very sick people among some organiza-
tions as well as new methods of controlling favorable
selection, at least in mandatory systems); (c) managed
care conserves resources and it operates at lower cost
(although savings may remain within the managed care
firm, depending upon the payment agreement in place);
(d) managed care receives lower satisfaction ratings on
all dimensions but financial and coverage aspects of plans
and such ratings vary with degree of impairment;
(e) managed care sometimes performs better and other
times worse in terms of acute care processes; (f) man-
aged care produces acute care outcomes which are no
better and possibly worse than those found in the FFS
sector; and (g) managed care does worse on the basis of
process and outcome indicators in treating the condi-
tions of a chronically ill, frail elderly population in both
nursing homes and home health settings.
FUTURE RESEARCH
The total number of studies addressing managed care
in an elderly population is scant and each is fraught with
problems ranging from selection bias to concerns about
generalizability from settings which may be unique in
many respects. Within these limitations, however, pre-
liminary results indicate that managed care offers sub-
stantial promise for reducing costs of caring for elderly
people. They also indicate that favorable selection will
occur if not constrained by payer policies, brokers, or
ameliorated by incentives that make managed care more
attractive to chronically ill people. Quality of care find-
ings are a particular concern, indicating that care
processes and outcome in acute and especially long-term
care settings need considerable attention and improve-
ment. Researchers must move beyond their previous focus
on managed care’s average performance for the elderly
and begin to emphasize its effects on the most frail and
chronically ill. In view of significant government in-
volvement in financing acute and long-term care for those
65 and over through Medicare and Medicaid, the gov-
ernment role in structuring its relationship with managed
care contractors needs to be more carefully elucidated.
In short, many important questions remain, ranging
from validity and generalizability of findings accumu-
lated thus far to concerns barely addressed in past re-
search, such as the appropriate role of government.
Specifically, better research designs are badly needed to
substantiate old results and produce valid new ones. The
research agenda remaining is substantial and should in-
clude more rigorous longitudinal designs, more repre-
sentative studies, and more rural studies. Especially
needed are randomized controlled trials. Although these
are difficult to mount among Medicare beneficiaries, a
number of precedents exist, including many in long-term
care (e.g., see Refs. 58-60). Beneficiaries can be offered
expanded services in a managed care plan, then be ran-
domly assigned to managed care or traditional FFS if
they grant informed consent to participate in the study.
Without randomized trials, there is no way to overcome
the nagging uncertainties engendered by selection bi-
ases. Oddly, current policy demands such a level of rigor
for new drugs, but so far not for a change which would
seem to result in heretofore unprecedented major shifts
in care practices.
Equally lacking in the studies to date is any system-
atic testing of the relationship between managed care
plan features and care processes and outcomes. Resource
allocation decision-making rules employed by plans
should be made explicit to permit study of their effects
on cost savings on the one hand and consumer satisfac-
tion on the other. Although the field needs more time to
mature before rigid regulatory procedures lock out fur-
ther innovations, studies to date lack any systematic ef-
fort to identify plan features which deserve to be adopted
versus those which seem to be associated with inferior
performance. More needs to be known about the role of
quality assurance programs employed in each of the
demonstrations and study plans. Even less is known
about the relationship between the existing regulatory
environment and performance of plans’ quality assur-
ance mechanisms.
Other plan features and practices affect who enrolls
in plans. More systematic study is needed of how plans
market themselves, to whom, with what level of vigor,
and what barriers to entry they erect or fail to overcome
which tend to result in favorable selection into most
plans. Aspects may include features of selection of physi-
cians for their panels, types of benefits provided and lim-
its on their availability, access to primary and specialty
care providers, where the plans locate themselves and
their providers, what information they give to prospec-
tive enrollees, and other aspects of their recruitment and
enrollment process. Of particular interest is the poten-
tial for enrollment brokers to serve as unbiased agents
of the payer to assure that all enrollees receive equal
treatment and information about their plan options. A
particular concern with the enrollment process is the
need to develop enticements with which to encourage
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enrollment of a broader range of seniors, especially chron-
ically ill enrollees and those living in rural areas.
Much better methods of matching payment to costs
of delivering care are needed. Clearly the current AAPCC
formula overpays managed care plans and so was re-
vised in the 1997 Balanced Budget Agreement. Its ef-
’ 
fects are as yet unknown and likely to be complex. Yet
the challenge is to continue to encourage plans to offer
senior-attracting services while not resulting in excess
profit. fiCFA’s plans to further experiment with the com-
petitive bidding approach used in the Arizona Medicaid
demonstration projects offers substantial promise and
should be studied. Indeed, competitive bidding is just
one aspect of a largely missing ingredient in research
to date, the appropriate role of government in steering
and regulating the managed care field. How should gov-
ernment respond when 15% of enrollees report that they
are underserved by their managed care plan? Will mar-
ket forces solve the problem? Is it a concern of gov-
ernment when freedom of choice of provider is
restricted, care is denied, plans reject powerful or pop-
ular providers, hospitals close, nonenrolled beneficia-
ries’ premiums, co-pays, and other out-of-pocket
expenses rise, and plans fail?
A similar set of questions could be asked about the
role of consumer advocacy groups and the foundations
which sometimes support them. Clearly they must be-
come expert in interpreting the implications of incen-
tives built into capitation formulas. They must identify
tracer conditions and subgroups likely to be ill served
by managed care and learn to monitor and advocate on
their behalf. And they must become sophisticated in eval-
uating research findings on the relative effectiveness and
efficiency of some care modalities relative to others if
they are to avoid losing or meaningless battles for care
likely not to be worth the fight. Groups such as the
American Association for Retired Persons regional, state,
and local groups and the Citizens’ Coalition for Better
Care must learn to interpret provisions of public bid so-
licitations, selection criteria used to choose plans, con-
tract requirements determining the nature of provider
networks, and details of benefit requirements including
service definitions and quality assurance requirements
imposed by states on Medicaid plans and plans on their
providers. Are these realistic roles for consumer groups
advocating on behalf of elderly enrollees, and if so, what
are the best ways in which to train staff and volunteers
to play these important roles?
These pressing questions remain largely unanswered
although they lie behind policy choices faced on a daily
basis by policy makers considering the appropriate role
of managed care in caring for elderly enrollees in
Medicaid, Medicare, and retiree health plans. A sub-
stantial research agenda should be undertaken directed
less at answering the question of how well managed care
performs compared to FFS arrangements, but rather how
to design managed care so that it performs at least as
well as FFS care at lower cost, and how to most effec-
tively use the other actors in the health care system to
help shape managed care to make it most effective, effi-
cient, and satisfactory to chronically ill elderly people
and other vulnerable populations.
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